News

Atrys Health draws €8M bridge loan from director-linked firm to repay bonds

What's the deal? Atrys Health, a Spanish health-tech group, has signed an €8 million bridge loan with The Nimo's Holding, a company linked to board member Josep María Echarri Torres. The loan, approved by the board on November 11, will help Atrys repay a convertible bond maturing on November 17.

Why now? The 2020 bonds leave €7 million in principal outstanding, plus roughly €1.26 million in accrued interest, for a total of €8.26 million. Atrys will cover the remaining €260,392 with its own funds. Long-term financing it is negotiating will not close before the bonds come due.

The terms: The loan carries three-month Euribor, floored at 0%, plus a 3.5% margin — an effective annual cost near 6.2%. Atrys says that beats a working-capital facility priced near 8%, an October offer above 11%, and a July 2025 shareholder loan at 10%.

The loan matures when Atrys completes its debt reorganisation, or by December 31, 2026 at the latest. Once long-term financing closes, the principal will offset against The Nimo's Holding's committed stake in that financing. Five subsidiaries guarantee the obligations.

What could go wrong? This is a stopgap, not growth capital. The company has not yet closed its new financial structure, and the pending restructuring — not the loan itself — remains the open question. January's €145 million sale of its ASPY prevention unit cut net financial debt to €35.4 million at the half-year.

The signal: As a related-party deal, the loan drew prior review from Atrys's audit committee, which issued a favourable report. Echarri controls the lender as majority owner and joint administrator. The arrangement underscores how Atrys keeps leaning on insiders to bridge gaps while it negotiates a broader fix.

Read more: bolsamania.com

Image credit: Generated with Gemini

More top stories